Applying our “rectangular” strategy for biomarker discovery (Geyer et al, 2017), we discovered 361 and 237 significantly altered proteins in PD patients and pathogenic LRRK2 carriers, respectively. The gene discussed is LRRK2; the disease is Parkinson disease.